A High-Content Screening Technology for Quantitatively Studying Podocyte Dynamics

Satchell, 2009, Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier, Am J Physiol Ren Physiol, 296, F947, 10.1152/ajprenal.90601.2008 Miner, 2012, The glomerular basement membrane, Exp Cell Res, 318, 973, 10.1016/j.yexcr.2012.02.031 Mundel, 1995, Structure and function of podocytes: an update, Anat Embryol (Berl), 192, 385, 10.1007/BF00240371 Pavenstädt, 2003, Cell biology of the glomerular podocyte, Physiol Rev, 83, 253, 10.1152/physrev.00020.2002 Reiser, 2000, The glomerular slit diaphragm is a modified adherens junction, J Am Soc Nephrol, 11, 1, 10.1681/ASN.V1111 Ichimura, 2003, Actin filament organization of foot processes in rat podocytes, J Histochem Cytochem, 51, 1589, 10.1177/002215540305101203 Reiser, 2016, Podocytes, F1000 Res, 5, 10.12688/f1000research.7255.1 Faul, 2007, Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton, Trends Cell Biol, 17, 428, 10.1016/j.tcb.2007.06.006 Reiser, 2010, Toward the development of podocyte-specific drugs, Kidney Int, 77, 662, 10.1038/ki.2009.559 Lee, 2015, A podocyte-based automated screening assay identifies protective small molecules, J Am Soc Nephrol, 26, 2741, 10.1681/ASN.2014090859 Farquhar, 1975, Editorial: the primary glomerular filtration barrier—basement membrane or epithelial slits?, Kidney Int, 8, 197, 10.1038/ki.1975.103 Kriz, 1995, Structure-stabilizing forces in the glomerular tuft, J Am Soc Nephrol, 5, 1731, 10.1681/ASN.V5101731 Embry, 2016, Biochemical and cellular determinants of renal glomerular elasticity, PLoS One, 11, e0167924, 10.1371/journal.pone.0167924 Endlich, 2012, The challenge and response of podocytes to glomerular hypertension, Semin Nephrol, 32, 327, 10.1016/j.semnephrol.2012.06.004 Takami, 1991, Ultrastructure of glomerular basement membrane by quick-freeze and deep-etch methods, Kidney Int, 39, 659, 10.1038/ki.1991.79 Drenckhahn, 1988, Ultrastructural organization of contractile and cytoskeletal proteins in glomerular podocytes of chicken, rat, and man, Lab Invest, 59, 673 Shirato, 1996, Cytoskeletal changes in podocytes associated with foot process effacement in masugi nephritis, Am J Pathol, 148, 1283 Hara, 1995, Urinary excretion of podocalyxin indicates glomerular epithelial cell injuries in glomerulonephritis, Nephron, 69, 397, 10.1159/000188509 Petermann, 2003, Podocytes that detach in experimental membranous nephropathy are viable, Kidney Int, 64, 1222, 10.1046/j.1523-1755.2003.00217.x Mundel, 2002, Podocyte biology and response to injury, J Am Soc Nephrol, 13, 3005, 10.1097/01.ASN.0000039661.06947.FD Kriz, 1996, Progressive renal failure-inability of podocytes to replicate and the consequences for development of glomerulosclerosis, Nephrol Dial Transpl, 11, 1738 Kriz, 2005, Pathways to nephron loss starting from glomerular diseases-insights from animal models, Kidney Int, 67, 404, 10.1111/j.1523-1755.2005.67097.x Altintas, 2015, Bridges to cross, burn, and mend: cells of renin lineage as podocyte progenitors, Am J Physiol Ren Physiol, 309, F499, 10.1152/ajprenal.00301.2015 Wiggins, 2007, The spectrum of podocytopathies: a unifying view of glomerular diseases, Kidney Int, 71, 1205, 10.1038/sj.ki.5002222 2014 Durvasula, 2006, Podocyte injury and targeting therapy: an update, Curr Opin Nephrol Hypertens, 15, 1, 10.1097/01.mnh.0000199012.79670.0b Leeuwis, 2010, Targeting podocyte-associated diseases, Adv Drug Deliv Rev, 62, 1325, 10.1016/j.addr.2010.08.012 Mathieson, 2011, The podocyte as a target for therapies – new and old, Nat Rev Nephrol, 8, 52, 10.1038/nrneph.2011.171 Mundel, 1997, Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines, Exp Cell Res, 236, 248, 10.1006/excr.1997.3739 Saleem, 2002, A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression, J Am Soc Nephrol, 13, 630, 10.1681/ASN.V133630 Shankland, 2007, Podocytes in culture: past, present, and future, Kidney Int, 72, 26, 10.1038/sj.ki.5002291 Mundel, 1997, Synaptopodin: an actin-associated protein in telencephalic dendrites and renal podocytes, J Cell Biol, 139, 193, 10.1083/jcb.139.1.193 Asanuma, 2005, Synaptopodin regulates the actin-bundling activity of alpha-actinin in an isoform-specific manner, J Clin Invest, 115, 1188, 10.1172/JCI200523371 Reiser, 2004, Podocyte migration during nephrotic syndrome requires a coordinated interplay between cathepsin L and alpha3 integrin, J Biol Chem, 279, 34827, 10.1074/jbc.M401973200 Taylor, 2007, Past, present, and future of high content screening and the field of cellomics, Methods Mol Biol, 356, 3 Zanella, 2010, High content screening: seeing is believing, Trends Biotechnol, 28, 237, 10.1016/j.tibtech.2010.02.005 Perlman, 2004, Multidimensional drug profiling by automated microscopy, Science, 306, 1194, 10.1126/science.1100709 Boutros, 2015, Microscopy-based high-content screening, Cell, 163, 1314, 10.1016/j.cell.2015.11.007 Whiteside, 1993, Podocytic cytoskeletal disaggregation and basement-membrane detachment in puromycin aminonucleoside nephrosis, Am J Pathol, 142, 1641 Fishman, 1985, Effects of the aminonucleoside of puromycin on glomerular epithelial cells in vitro, Am J Pathol, 118, 398 Marshall, 2006, Puromycin aminonucleoside induces oxidant-dependent DNA damage in podocytes in vitro and in vivo, Kidney Int, 70, 1962, 10.1038/sj.ki.5001965 Buchser, 2004, Assay development guidelines for image-based high content screening, high content analysis and high content imaging Takeuchi, 2010, The immunosuppressive drug mizoribine directly prevents podocyte injury in puromycin aminonucleoside nephrosis, Nephron Exp Nephrol, 116, e3, 10.1159/000314668 Wada, 2005, Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: role of p53 and Bcl-2-related family proteins, J Am Soc Nephrol, 16, 2615, 10.1681/ASN.2005020142 Zhang, 1999, A simple statistical parameter for use in evaluation and validation of high throughput screening assays, J Biomol Screen, 4, 67, 10.1177/108705719900400206 Singh, 2014, Increasing the content of high-content screening: an overview, J Biomol Screen, 19, 640, 10.1177/1087057114528537 Ramirez, 2010, Cell viability assessment: toward content-rich platforms, Expert Opin Drug Discov, 5, 223, 10.1517/17460441003596685 Antczak, 2009, Live-cell imaging of caspase activation for high-content screening, J Biomol Screen, 14, 956, 10.1177/1087057109343207 Xu, 2010, Revealing a core signaling regulatory mechanism for pluripotent stem cell survival and self-renewal by small molecules, Proc Natl Acad Sci USA, 107, 8129, 10.1073/pnas.1002024107 Adler, 1992, Characterization of glomerular epithelial cell matrix receptors, Am J Pathol, 141, 571 Pozzi, 2008, Beta1 integrin expression by podocytes is required to maintain glomerular structural integrity, Dev Biol, 316, 288, 10.1016/j.ydbio.2008.01.022 Kanasaki, 2008, Integrin beta1-mediated matrix assembly and signaling are critical for the normal development and function of the kidney glomerulus, Dev Biol, 313, 584, 10.1016/j.ydbio.2007.10.047 Widmeier, 2017, A small molecule screening to detect potential therapeutic targets in human podocytes, Am J Physiol Ren Physiol, 312, F157, 10.1152/ajprenal.00386.2016 Gupta, 2017, Stop that podocyte!, Am J Physiol Ren Physiol, 312, F373, 10.1152/ajprenal.00499.2016